Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Carbetocin at Cesarean Delivery for Labour Arrest

A Sequential Allocation Trial to Determine the Effective Dose

Nguyen-Lu, N.; Carvalho, J.C.; Farine, D.; Seaward, G.; Ye, X.Y.; Balki, M.

Obstetric Anesthesia Digest: June 2016 - Volume 36 - Issue 2 - p 79–80
doi: 10.1097/01.aoa.0000482613.87420.28
Mechanisms, Equipment, Hazards
Buy
Commentary

(Can J Anesth. 2015;62:866–874)

Currently, oxytocin is the primary drug used to reduce the incidence of postpartum hemorrhage. However, oxytocin does have limitations, including a half-life of only 4 to 10 minutes, administration by means of an intravenous infusion, and a high rate of dose-dependent adverse effects. In contrast, carbetocin is administered as a single intravenous dose, but the recommended dosages are not well established. The authors of this study sought to determine an effective dose of carbetocin to provide satisfactory uterine tone following an intrapartum cesarean delivery in parturients whose labors were augmented.

Department of Anesthesia and Pain Management, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved